From Livemint
Center-Right Owned by HT Media Ltd.Drugmakers may need designated expert to certify batches before sale
What's behind this
The centre has proposed amendments to the drugs rules that would require manufacturers to formally authorise a qualified person with appropriate experience to release each batch and keep prescribed records; this could mean drugmakers need a designated expert to certify batches before sale, a development seen as significant for India’s $60‑billion pharmaceutical industry amid concerns over drug quality.
AI-generated overview from 2 outlets. It summarises their reporting and adds no reporting of its own.
What each side is saying
One outlet's own words from each side of the spectrum. Quoted, not summarised.
-
right · 1 outlet
The development assumes significance for India's $60-billion pharmaceutical industry amid concerns over the quality of drugs manufactured in the country.
— Livemint
RSS excerpt
The development assumes significance for India's $60-billion pharmaceutical industry amid concerns over the quality of drugs manufactured in the country.
